Articles tagged with: Health
Cardiomyopathies Matter: Time to tackle under-recognised cardiovascular diseases Partner Content
02 Dec Opinion
Cardiomyopathies Matter: Time to tackle under-recognised cardiovascular diseases
MEP Dr Juozas Olekas, together with experts participating in the Cardiomyopathies Matter initiative, Prof. Iacopo Olivotto and Dr Patricia Vlasman, call on EU and national decision-makers to recognise and address the substantial burden of cardiomyopathies on patients, families, healthcare systems and societies.
What Europe needs to achieve a sustainable blood ecosystem Partner Content
12 Oct Opinion
What Europe needs to achieve a sustainable blood ecosystem
As a new EU Regulation governing the field of Substances of human origins (SoHO) is being shaped, let’s look at the bigger picture, including factors that impact blood demand and opportunities to reduce the drain on the healthcare systems, says Antonis Kattamis, who is involved in the Blood and Beyond initiative
Animal experiments – how many times do we have to say enough is enough? Partner Content
06 Sep
Animal experiments – how many times do we have to say enough is enough?
For a record second time, citizens have overwhelmingly told the European Commission that they want an end to animal experiments in the EU.
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer Partner Content
01 Jul
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer
A political commitment to unleash the life-saving potential of the EU Pharmaceutical Strategy is needed say Gilles Vassal, Board Member of SIOP Europe, and Delphine Heenen, Committee Member of CCI Europe.
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry Partner Content
27 Jun
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry
Prominent MEPs seeking quicker wins for rare disease patients are backing closer collaboration between Europe’s reference networks and pharma companies through a novel multistakeholder initiative.
One Health: Healthy animals, healthier people, and a healthier planet Partner Content
23 Jun
One Health: Healthy animals, healthier people, and a healthier planet
Experts meeting at an event in Brussels discuss how AnimalHealthEurope‘s One Health strategy can succeed in achieving better health for both animals and people.
Uneven progress in contraception protection across Europe Partner Content
01 Mar
Uneven progress in contraception protection across Europe
Europe has among the highest use of contraceptives and the lowest abortion rates in the world, but progress is still uneven among member states especially in Eastern Europe
Tackling rare diseases through enhanced coordination Partner Content
28 Feb
Tackling rare diseases through enhanced coordination
European Reference Networks, support for research, and the revision of EU medicines legislation, is key to the Commission’s plans for helping people suffering from rare diseases
Learning from the rare disease community Partner Content
25 Feb
Learning from the rare disease community
Europe’s pharmaceutical entrepreneurs are taking the lessons learned from this community to develop health innovation which would not have been dreamt of a few decades ago
Rare Diseases: Towards a patient-centred EU Blood Directive Partner Content
24 Feb
Rare Diseases: Towards a patient-centred EU Blood Directive
For rare disease patients who rely on plasma-derived medicinal products, supply has become the major safety issue
Rare Diseases: EU Orphan Regulation, backing innovation to address unmet needs Partner Content
23 Feb
Rare Diseases: EU Orphan Regulation, backing innovation to address unmet needs
Our capacity to keep on developing new treatments for people living with rare disease depends on Europe’s research ecosystem
Transforming Rare Diseases Partner Content
21 Feb
Transforming Rare Diseases
A special supplement looking at how Europe can come together to find solutions for people suffering from a rare disease
Europe’s time to act on rare diseases Partner Content
21 Feb
Europe’s time to act on rare diseases
Renewed collaboration at EU level for a new joint strategy on rare diseases could transform the rare disease landscape for patients
Why we need an EU Childhood Cancer Advisory Board Partner Content
28 Jan
Why we need an EU Childhood Cancer Advisory Board
The European childhood cancer community is calling for the creation of a multi-stakeholder body to help cure more children, cure them better and reduce inequalities say Carmelo Rizzari President of the European Society for Paediatric Oncology (SIOP Europe) and Gilles Vassal Board Member of SIOP Europe and Chair of ACCELERATE
40 years of HIV pandemic: key learnings for the future of global health Partner Content
17 Dec
40 years of HIV pandemic: key learnings for the future of global health
AHF Europe’s Zoya Shabarova reflects on the lessons learned fighting the AIDS/HIV pandemic and how these can be applied to a future international pandemic agreement
Why the world needs an International Pandemic Agreement Partner Content
26 Nov
Why the world needs an International Pandemic Agreement
AHF Europe’s Anna Maria Żakowicz explains how to strengthen the International Pandemic Agreement by applying an inclusive decision-making approach
Why vaccination matters now more than ever Partner Content
27 Sep
Why vaccination matters now more than ever
Pfizer's Sinan Atlig and MEP Sara Cerdas explain why, with winter fast approaching, we must use the lessons learned from the pandemic to vaccinate society's most vulnerable against other harmful respiratory viruses.
Why perioperative care and effective monitoring matters Partner Content
23 Sep
Why perioperative care and effective monitoring matters
A group of clinicians and patient group representatives, called the ImPrOve Think Tank, recently convened to address a common complication during high-risk surgery they consider to be most urgent and dangerous; haemodynamic instability characterised as significant drops in blood pressure.
European Health Union: Our number one priority
29 Jul
European Health Union: Our number one priority
The COVID-19 pandemic has highlighted both the importance of our health care systems and the extent to which we have allowed them to deteriorate; we must reverse this process, says Alessandra Moretti
Plasma-derived Medicinal Products: It’s in us all to save a life
16 Jun
Plasma-derived Medicinal Products: It’s in us all to save a life
EU policymakers must do more to ensure better patient access to plasma-derived medicinal products, writes Manuel Pizarro.
Access to healthcare: EU health inequalities persist
02 Jun
Access to healthcare: EU health inequalities persist
The COVID-19 crisis has highlighted the inequalities in our healthcare systems; we should prioritise these, not pharma profits, writes Michèle Rivasi.
How do we solve the rare disease crisis? Partner Content
27 May
How do we solve the rare disease crisis?
Pfizer often made the headlines over the past year after mobilising their scientific expertise and manufacturing capabilities to respond to the COVID-19 pandemic. Reda Guiha, Regional President for Rare Disease at Pfizer, argues that the same sense of urgency and public-private sector collaboration that brought vaccines to patients within a year should be applied to other areas of critical unmet medical need, such as rare disease.
Issue 536 | 24 May 2021
21 May
Issue 536 | 24 May 2021
The latest edition of The Parliament Magazine is now available to read online for free.
Air pollution is a public health and climate emergency the EU can no longer ignore Partner Content
07 May
Air pollution is a public health and climate emergency the EU can no longer ignore
In an open letter, European health industry leaders call on the European Commission to urgently develop the Green Pillar of the European Health Union for a healthy recovery from the pandemic.